Select a Region North America


Mike Kurland

Michael Kurland

Vice President, Revenue Management & Compliance Solutions


Revenue Management

With more than 2 decades of experience in the pharmaceutical and biotech industries, Michael helps clients navigate the complex public and private payer marketplace. He has a proven reputation for helping manufacturers balance their market share goals and commercial rebate strategies with government pricing impacts and compliance.

Throughout his career, Michael has developed, implemented, and managed business strategies and technical solutions for government pricing, market access, rebate and chargeback processing and data analytics. And, in this context, it makes perfect sense that his areas of expertise include government pricing compliance, public payer strategy development, business analysis, project management, process and system reviews, selections and implementations, and cross-functional team management. Previously, Michael served as director at several life science consulting firms, as well as associate director of government regulated systems at Auxilium Pharmaceuticals, Inc. He holds a bachelor of science degree from Penn State University.

Events with Michael Kurland

Articles by Michael Kurland

Global Pharma Pricing Regulations
Webinar: Medicaid & Government Pricing Congress

In this Medicaid & Government Pricing Congress panel, EVERSANA’s Mike Kurland, Vice President, Revenue Management and Compliance Solutions, discusses upcoming regulatory changes impacting government pricing and how to manage challenging reporting issues with calculation. How to Manage Challenging Reporting Issues with Calculation​ This panel covers: Operational components Legal components Aligning with internal/external teams on handling […]

Webinar: Drug Pricing and Reporting Regulatory Updates Part 2

In Part 2 of our Drug Pricing and Reporting Regulatory Updates webinar, EVERSANA revenue experts Michael Kurland and Brian Bumpus take a look at the Final Rule, which was released by the Centers for Medicare and Medicaid Services in December 2020. Legislative actions related to the rule will go into effect through 2023. This webinar […]

Webinar: Drug Pricing and Reporting Regulatory Updates Part 1

Pharmaceutical companies in the U.S. are navigating President Biden’s new administration and legislative changes that are affecting pricing and regulatory actions.   One of these changes includes the regulatory freeze ordered for actions made in the final two months of the Trump administration, which has paused Medicare Part B and Medicare Part D legislation as well.  In part one of our drug pricing and reporting […]

Drug Pricing And Drug Price Reporting Regulatory Update

As the new president and Congress begin their terms, EVERSANA would like to provide an update on recent legislative and regulatory actions that affect drug pricing and price reporting. The Centers for Medicare and Medicaid Services (CMS) issued this interim final rule on November 20, 2020 (85 Fed Reg 76180-76259), requiring a revised calculation of […]

Challenges and Best Practices in Managing Value Based Contracts

Manufacturers face a variety of hurdles when negotiating value based contracts: from data access and standardization, deal structure variation, payment variability and scheduling, to changing laws and regulations. And, as the industry shifts to value-driven healthcare, the demand for innovative product commercialization and pricing models grows. In this webinar EVERSANA experts Robert Blank and Mike […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.